Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter
- PMID: 29929450
- DOI: 10.1080/09638288.2018.1481149
Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter
Abstract
Objective: Despite the growing evidence of physiological and cellular abnormalities in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS), there has been a strong impetus to tackle the illness utilizing a biopsychosocial model. However, many sufferers of this disabling condition report distress and dissatisfaction following medical encounters. This review seeks to account for this discord.Methods: A narrative review methodology is employed to synthesize the evidence for potential iatrogenesis.Results: We identify seven potential modalities of iatrogenesis or harm reported by patients:difficulties in reaching an acceptable diagnosis;misdiagnosis, including of other medical and psychological conditions;difficulties in accessing the sick role, medical care and social support;high levels of patient dissatisfaction with the quality of medical care;negative responses to controversial therapies (cognitive behavioral therapy and graded exercise therapy);challenges to the patient narrative and experience;psychological harm (individual and collective distress).Conclusion: The biopsychosocial framework currently applied to ME/CFS is too narrow in focus and fails to adequately incorporate the patient narrative. Misdiagnosis, conflict, and harm are observable outcomes where doctors' and patients' perspectives remain incongruent. Biopsychosocial practices should be scrutinized for potential harms. Clinicians should consider adopting alternative patient-centred approaches.Implications for rehabilitationPatients with ME/CFS may report or experience one or more of the modalities of harms and distress identified in this review.It is important health and rehabilitation professionals seek to avoid and minimize harms when treating or assisting ME/CFS patients.There are conflicting models of ME/CFS; we highlight two divergent models, a biopsychosocial model and a biomedical model that is preferred by patients.The 'biopsychosocial framework' applied in clinical practice promotes treatments such as cognitive behavioral therapy and exercise therapy, however, the evidence for their success is contested and many patients reject the notion their illness is perpetuated by dysfunctional beliefs, personality traits, or behaviors.Health professionals may avoid conflict and harm causation in ME/CFS by adopting more concordant 'patient-centred' approaches that give greater prominence to the patient narrative and experience of illness.
Keywords: Chronic fatigue syndrome; biopsychosocial model; doctor–patient relationship; harm; iatrogenesis; treatment.
Similar articles
-
Impact of the COVID-19 Pandemic and the 2021 National Institute for Health and Care Excellence Guidelines on Public Perspectives Toward Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Thematic and Sentiment Analysis on Twitter (Rebranded as X).J Med Internet Res. 2025 May 21;27:e65087. doi: 10.2196/65087. J Med Internet Res. 2025. PMID: 40397934 Free PMC article.
-
Important factors to consider when treating children with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): perspectives of health professionals from specialist services.BMC Pediatr. 2017 Feb 1;17(1):43. doi: 10.1186/s12887-017-0799-7. BMC Pediatr. 2017. PMID: 28143516 Free PMC article.
-
Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.Rev Environ Health. 2015;30(4):223-49. doi: 10.1515/reveh-2015-0026. Rev Environ Health. 2015. PMID: 26613325 Review.
-
A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.Neuro Endocrinol Lett. 2009;30(3):284-99. Neuro Endocrinol Lett. 2009. PMID: 19855350 Review.
-
Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Evid Rep Technol Assess (Full Rep). 2014 Dec;(219):1-433. doi: 10.23970/AHRQEPCERTA219. Evid Rep Technol Assess (Full Rep). 2014. PMID: 30313001
Cited by
-
One or many labels? a longitudinal qualitative study of patients' journey to diagnosis at a specialist NHS Postural Tachycardia Syndrome (PoTS) clinic.PLoS One. 2024 Jul 10;19(7):e0302723. doi: 10.1371/journal.pone.0302723. eCollection 2024. PLoS One. 2024. PMID: 38985772 Free PMC article.
-
[Validation of subjective complaints: differential diagnosis of "healthy suffering" using fatigue as an example].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Nov;67(11):1264-1272. doi: 10.1007/s00103-024-03963-w. Epub 2024 Oct 14. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024. PMID: 39400559 Free PMC article. Review. German.
-
Chronic fatigue syndrome and an illness-focused approach to care: controversy, morality and paradox.Med Humanit. 2019 Jun;45(2):183-187. doi: 10.1136/medhum-2018-011598. Epub 2019 Jun 18. Med Humanit. 2019. PMID: 31213482 Free PMC article.
-
Rethinking the Standard of Care for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.J Gen Intern Med. 2020 Mar;35(3):906-909. doi: 10.1007/s11606-019-05375-y. Epub 2019 Oct 21. J Gen Intern Med. 2020. PMID: 31637650 Free PMC article. No abstract available.
-
Treating medically unexplained symptoms via improving access to psychological therapy (IAPT): major limitations identified.BMC Psychol. 2020 Feb 5;8(1):13. doi: 10.1186/s40359-020-0380-2. BMC Psychol. 2020. PMID: 32020880 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical